ITOS
Price
$17.90
Change
-$0.06 (-0.33%)
Updated
May 16, 6:59 PM EST
82 days until earnings call
RCUS
Price
$17.45
Change
-$0.13 (-0.74%)
Updated
May 16, 6:59 PM EST
76 days until earnings call
Ad is loading...

ITOS vs RCUS

Header iconITOS vs RCUS Comparison
Open Charts ITOS vs RCUSBanner chart's image
iTeos Therapeutics
Price$17.90
Change-$0.06 (-0.33%)
Volume$216.2K
CapitalizationN/A
Arcus Biosciences
Price$17.45
Change-$0.13 (-0.74%)
Volume$141.15K
CapitalizationN/A
View a ticker or compare two or three
ITOS vs RCUS Comparison Chart

Loading...

ITOSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RCUSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ITOS vs. RCUS commentary
May 17, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITOS is a Hold and RCUS is a StrongBuy.

COMPARISON
Comparison
May 17, 2024
Stock price -- (ITOS: $17.90 vs. RCUS: $17.46)
Brand notoriety: ITOS and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ITOS: 100% vs. RCUS: 96%
Market capitalization -- ITOS: $648.77M vs. RCUS: $1.6B
ITOS [@Biotechnology] is valued at $648.77M. RCUS’s [@Biotechnology] market capitalization is $1.6B. The market cap for tickers in the [@Biotechnology] industry ranges from $592.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ITOS’s FA Score shows that 1 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • ITOS’s FA Score: 1 green, 4 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, ITOS is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ITOS’s TA Score shows that 6 TA indicator(s) are bullish while RCUS’s TA Score has 5 bullish TA indicator(s).

  • ITOS’s TA Score: 6 bullish, 5 bearish.
  • RCUS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ITOS is a better buy in the short-term than RCUS.

Price Growth

ITOS (@Biotechnology) experienced а +46.84% price change this week, while RCUS (@Biotechnology) price change was +8.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.53%. For the same industry, the average monthly price growth was +5.10%, and the average quarterly price growth was +62.66%.

Reported Earning Dates

ITOS is expected to report earnings on Aug 07, 2024.

RCUS is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Biotechnology (+3.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ITOS with price predictions.
OPEN
A.I.dvisor published
a Summary for RCUS with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
RCUS($1.6B) has a higher market cap than ITOS($649M). ITOS YTD gains are higher at: 63.470 vs. RCUS (-8.586).
ITOSRCUSITOS / RCUS
Capitalization649M1.6B41%
EBITDAN/AN/A-
Gain YTD63.470-8.586-739%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
76
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ITOSRCUS
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 12 days ago
75%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 10 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
73%
View a ticker or compare two or three
Ad is loading...
ITOSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RCUSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFCSX43.960.18
+0.41%
Hennessy Focus Investor
PIEMX40.41N/A
N/A
Principal Equity Income R1
DFUEX26.16-0.10
-0.38%
DFA US Social Core Equity 2 Portfolio
RYBIX87.88-0.42
-0.48%
Rydex Basic Materials Inv
GCIFX14.11-0.07
-0.49%
Green Century MSCI Intl Indx Instl

ITOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITOS has been loosely correlated with RCUS. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ITOS jumps, then RCUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITOS
1D Price
Change %
ITOS100%
-0.33%
RCUS - ITOS
54%
Loosely correlated
-0.51%
ADMA - ITOS
51%
Loosely correlated
-0.44%
VSTM - ITOS
45%
Loosely correlated
-7.55%
NRIX - ITOS
42%
Loosely correlated
-3.14%
LABP - ITOS
42%
Loosely correlated
N/A
More

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with ITOS. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then ITOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
-0.51%
ITOS - RCUS
54%
Loosely correlated
-0.33%
NTLA - RCUS
46%
Loosely correlated
-0.19%
VSTM - RCUS
45%
Loosely correlated
-7.55%
AGIO - RCUS
44%
Loosely correlated
-0.51%
ALLO - RCUS
43%
Loosely correlated
+1.01%
More